Myristic Acid

Myristic Acid

SCHEMBL3299115

CCCCCCCCCCCCCC(=O)O.O=C1CCC(=O)N1O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.61
PPARG P37231 7/20 0.61
PPARD Q03181 7/20 0.61
PPARA Q07869 7/20 0.61
HDAC11 Q96DB2 5/20 0.61
TSHR P16473 4/20 0.61
PTPN1 P18031 3/20 0.61
FABP4 P15090 3/20 0.61
ALDH1A1 P00352 2/20 0.61
TLR2 O60603 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
KMT2A Q03164 2/20 0.61
ALOX15 P16050 2/20 0.61
HSD17B10 Q99714 2/20 0.61
SLC22A6 Q4U2R8 1/20 0.61
SLC22A8 Q8TCC7 1/20 0.61
MEN1 O00255 1/20 0.61
ESR1 P03372 1/20 0.61
PDE4A P27815 1/20 0.61
PDE3A Q14432 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Palmitic Acid SCHEMBL1815959 1.00 GPR84 (0.61) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL4612415 1.00 GPR84 (0.61) GPR84PPARGPPARDPPARAHDAC11
Hexanoate SCHEMBL2098722 0.98 AKR1B1 (0.59) GPR84PPARGPPARDPPARAHDAC11
Valeric Acid SCHEMBL29098873 0.93 AKR1B1 (0.50) GPR84PPARGPPARDPPARAHDAC11
Oleic Acid SCHEMBL28630252 0.91 PPARG (0.68) PPARGPPARDPPARATSHRPTPN1
Azelaic Acid SCHEMBL28918234 0.91 TSHR (0.52) GPR84PPARGPPARDPPARAHDAC11
Adipic Acid SCHEMBL29427201 0.89 LMNA (0.50) GPR84PPARGPPARDPPARATSHR
Adipic Acid SCHEMBL906129 0.89 LMNA (0.50) GPR84PPARGPPARDPPARATSHR
Undecanoate SCHEMBL28399891 0.86 GPR84 (0.57) GPR84PPARGPPARDPPARAHDAC11
Sebacic Acid SCHEMBL29286911 0.85 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1543040-A1 SOLUBILISING POLYSACCHARIDES SUBSTITUTED WITH HYDROPHILIC AND HYDROPHOBIC GROUPS UNIVERSITY OF STRATHCLYDE (GB) 2005-06-22 EP claimed
WO-2004026912-A1 SOLUBILISING POLYSACCHARIDES SUBSTITUTED WITH HYDROPHILIC AND HYDROPHOBIC GROUPS THE UNIVERSITY OF STRATHCLYDE (GB) 2004-04-01 WO claimed
CN-114206902-B Method for modifying peptides immobilized on a solid support by means of a traceless reducing cleavable linker molecule 格瑞罗斯普罗泰恩科技公司 2025-02-21 CN disclosed
CN-117470799-B Method for detecting microplastic in water environment sediment 海南省环境科学研究院 2025-01-10 CN disclosed
CN-117470799-A Method for detecting microplastic in water environment sediment 海南省环境科学研究院 2024-01-30 CN disclosed
US-20230220123-A1 AMPHIPHILIC CARBOHYDRATE COMPOUNDS NANOMERICS LTD (GB) 2023-07-13 US disclosed
CN-116133690-A Amphiphilic carbohydrates 纳诺莫里克斯有限公司 2023-05-16 CN disclosed
EP-4153640-A1 AMPHIPHILIC CARBOHYDRATE COMPOUNDS Nanomerics Ltd (GB) 2023-03-29 EP disclosed
CN-114206902-A Method for modifying a peptide immobilized on a solid support by means of a traceless reductively cleavable linker molecule 贝兰迪克有限责任公司 2022-03-18 CN disclosed
WO-2021234413-A1 AMPHIPHILIC CARBOHYDRATE COMPOUNDS NANOMERICS LTD (GB) 2021-11-25 WO disclosed
CN-105820233-B Preparation method of insulin derivative 甘李药业股份有限公司 2021-06-15 CN disclosed
EP-1543040-B1 SOLUBILISING CHITOSAN POLYMER SUBSTITUTED WITH HYDROPHILIC AND HYDROPHOBIC GROUPS UNIV LONDON (GB) 2019-02-13 EP disclosed
EP-2857513-A1 SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR REGULATING EXPRESSION OF GENE HAVING DELIVERING FUNCTION Bonac Corporation (JP) 2015-04-08 EP disclosed
US-7741474-B2 Solubilising polysaccharides substituted with dydrophilic and hydrophobic groups THE SCHOOL OF PHARMACY, UNIVERSITY OF LONDON (GB) 2010-06-22 US disclosed
US-20060167116-A1 Solubilising polysaccharides substituted with dydrophilic and hydrophobic groups UNIVERSITY COLLEGE LONDON (GB) 2006-07-27 US disclosed
EP-0871665-A1 INSULIN DERIVATIVES NOVO NORDISK A/S (DK) 1998-10-21 EP disclosed
WO-1996029344-A1 INSULIN DERIVATIVES NOVO NORDISK A/S (DK) 1996-09-26 WO disclosed
US-5266576-A Anticarcinogenic agents ADIR ET COMPAGNIE (FR) 1993-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230220123-A1 AMPHIPHILIC CARBOHYDRATE COMPOUNDS ALG1, CETP, HDAC3 GPR84 1037/4885PPARG 1006/4885PPARD 975/4885
US-20060167116-A1 Solubilising polysaccharides substituted with dydrophilic and hydrophobic groups ALG1, DDOST, HEXD GPR84 1984/4885PPARG 3256/4885PPARD 2727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.